Our Objectives

Our Objectives

LuCE aims to raise awareness about inequities regarding the access to lung cancer treatment and care in Europe. Moreover, it advocates European policies that will lead to improvements in lung cancer prevention, early detection, treatment and care.

Read More

Our Members

Our Members

Lung Cancer Europe provides a European platform for national lung cancer patient advocacy groups and supports the establishment of those groups in countries where such groups do not yet exist. Our member organisations and associate members come from all over Europe.

Read More

Our Diagnosis

Our Diagnosis

Lung cancer is literally the biggest cancer killer worldwide – causing more deaths than breast and prostate cancer put together all over the world. Read more about our diagnosis, types and stages of lung cancer, treatments and clinical trials, but also how to cope with lung cancer.

Read More

2017 LuCE translated Report

During latest LuCE Report launching event, Stefania Vallone, LuCE’s President encouraged the attendees to give a step forward, and try working together to get improvement in access to innovative therapies and healthcare services, ensuring sustainability of different health-care systems and tackle the burden of this disease, offering more equal conditions to thousands of individuals across Europe affected by lung cancer. […]

Read More

Presentation: Patient perspective on lung cancer treatment progress

Stefania, Vallone, LuCE President, was key note speaker @IASLC Lung Cancer Immunotherapy Meeting, held between March 22-25, 2018 in Barcelona. She was presenting patient perspective on lung cancer treatment progress, by providing useful insight information on patient helth literacy on immunotherapy. You can find the presentation here: https://bit.ly/2I1IExi

Read More

Travel Awards to IASLC 2018 in Toronto

LuCE’s vice-president Ewelina Szmytke was among the interviewees on patients advocates attendance importance at IASLC World Conference on #LungCancer. You can apply for a patient advocate travel award following the interview link. In its efforts to increase links to patient advocates and advocacy organizations around the world, IASLC will offer travel awards to a limited number of patient advocates to attend […]

Read More

LuCE, among the main collaborators of 3rd ESO Masterclass in Cancer Patient Advocacy

This third edition of the Masterclass brought together senior representatives of European and international cancer patient networks as well as a small number of future leaders. The main topics covered were: • Lobbying for change • Building effective and sustainable EU cancer patient networks (leadership, effectiveness, challenges of working with industry, Boards) • Achieving sustainable access to cancer therapies • […]

Read More